可能存在慢性低剂量马射线诱导突变的剂量率值
Haruki Nagashima1, Kenshi Komatsu2, Hiroshi Tauchi1,3
1Institute for Environmental Science, 1-7 Ienomae, Obuchi, Rokkasho, Kamikita, Aomori 039-3212, Japan.
Radiation protection dosimetry
|November 14, 2024
概括
低剂量辐射暴露会导致体质突变. 这项研究确定了玛诱导突变频率在6.6和20mGy/day之间的拐点,这表明玛射线与三β辐射的突变机制不同.
科学领域:
- 辐射生物学 辐射生物学
- 分子毒理学分子毒理学
- 遗传学 遗传学 是一个
背景情况:
- 评估低剂量和低剂量辐射速率的生物效应至关重要.
- 要了解辐射诱导的损害,需要对体质突变进行敏感的检测.
- 素基因转移酶1 (HPRT1) 基因是突变研究的常见目标.
研究的目的:
- 建立一种敏感的测试方法来检测HPRT1基因中的体质突变.
- 为了研究玛辐射对突变发生的剂量率影响.
- 为了比较由玛射线和三β辐射诱导的突变性事件.
主要方法:
- 建立了一种敏感的测试系统,用于检测HPRT1基因中的体质突变.
- 暴露于马辐射的细胞的剂量为6.6,20和200mGy/day.
- 在HPRT1基因中分析了突变频率和突变光谱.
主要成果:
- 在6.6至20mGy/天之间的马诱导突变频率中确定了一个潜在的拐点.
- 在所有测试剂量速率上,与对照组相比,在突变谱中没有发现显著差异.
- 与之前的HTO暴露研究相比,发现了类似的突变频率,但与之前的HTO暴露研究相比,突变频谱趋势不同,特别是在200mGy/day.
结论:
- 与三β辐射相比,低剂量玛辐射具有明显的突变效应.
- 对于检测低剂量辐射效应,HPRT1基因突变试验具有敏感性.
- 在玛射线和三β辐射之间可能存在突变性事件的机制差异.
相关概念视频
Mutations
34.1K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
34.1K
Biological Effects of Radiation
15.3K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.3K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Nucleotide Excision Repair
3.4K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


